Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...

Thermo Fisher's core pharma, biotech, and bioproduction businesses are driving growth. Click here to read why TMO stock is a ...

The proposed regulator would mirror existing sectoral authorities such as IRDAI for insurance, SEBI for capital markets, and ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

While randomized controlled trials (RCTs) remain the gold standard in clinical research, integrating real-world evidence (RWE) through ECAs offers an opportunity to accelerate drug development and ...

Yaqrit has also appointed Amrik Shah as Chief Biometrics Officer. Amrik is a highly experienced biostatistician with 20+ years of experience in strategic design and analysis of clinical trials.

Yaqrit has also appointed Amrik Shah as Chief Biometrics Officer. Amrik is a highly experienced biostatistician with 20+ years of experience in strategic design and analysis of clinical trials. His ...

Press Releases CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India ACCESS Newswire April 29, 2025 9:01 AM ...